zydus

Zydus launches India’s first trivalent influenza vaccine VaxiFlu for seasonal flu protection

Zydus Lifesciences has launched VaxiFlu, India’s first trivalent influenza vaccine for seasonal flu protection. The vaccine follows WHO’s 2025–26 guidelines…

September 2, 2025 15:41 IST

Big pharma bet: Jefferies lists out India’s next CRDMO multibaggers with up to 37% upside potential

Growth prescription: The future is specialty; Sun Pharma, Dr Reddy’s, Cipla lead, says Nomura

Nomura’s June 2025 analysis shows Indian pharma majors like Sun Pharma, Dr. Reddy’s, Cipla, Lupin, and Zydus posting strong specialty…

August 11, 2025 16:58 IST

Torrent Pharma's Strategic Acquisition Transforms Market Position. (Image Source: Canva)

Torrent Pharma – M&A driven growth strategy

Torrent Pharma will emerge among the top 5 domestic pharma players by sales with the acquisition of J B Chemicals…

July 1, 2025 06:00 IST

Stocks to watch today: From Jio Financial, Vodafone Idea to Hero MotoCorp – Here are 8 stocks in focus

Discover why Jio Financial, Vodafone Idea, and 6 other stocks are in focus today – explore the market moves and…

June 19, 2025 06:22 IST

Is Zydus Lifesciences heading for a 10% decline in 12 months? Nuvama reveals 3 key reasons

Nuvama downgrades Zydus Lifesciences: Nuvama predicts a 10% drop in Zydus Lifesciences’ stock; explore the reasons now!

June 5, 2025 09:31 IST

Zydus Lifesciences, Pharmaceutical, healthcare, pharma, health

With plans to acquire US-based genus Inc, Zydus Lifesciences set to enter the global biologics CDMO business

Zydus Lifesciences plans to acquire US-based Agenus Inc, entering the global biologics CDMO market with two California facilities. The deal…

June 4, 2025 05:09 IST

Zydus Lifesciences, Q4 results, fourth quarter, revenue, EBITDA, profit, dividend

Zydus Life Q4 Results: Profit drops marginally to Rs 1,170.90 crore; final dividend of Rs 11 announced

Zydus Lifesciences posted Q4 profit at Rs 1,170.90 crore, marginally lower than Rs 1182.30 crore recorded during the corresponding quarter…

Updated: May 20, 2025 14:17 IST

Nifty Pharma Index, BSE Healthcare Index, pharma stocks today

Nomura’s top pharma bets include Dr. Reddy’s, Cipla, Lupin and Zydus

Nomura recommends Buy for Dr. Reddy’s, Cipla, Lupin, Zydus amid pharma stock pressure. Check latest market trends!

May 2, 2025 16:05 IST

Trump tariff, pharma stocks surge, Nifty Pharma Index, US-India trade,

Trump tariff impact: Pharma stocks surge over 4% on tariff exemption

Pharma stocks surge as Trump’s tariff exemption boosts sector morale. Dive into this bullish trend today!

April 3, 2025 10:45 IST

Three reasons why pharma stocks are falling today?

Pharma stocks are under significant selling pressure. Here is a detailed analysis on the top worries for the sector.

Updated: March 25, 2025 14:45 IST

Zydus Lifesciences soars 3% on US FDA nod for manufacturing Apalutamide Tablets

Zydus Lifesciences share price today, March 19: Zydus soars on US FDA approval for Apalutamide tablets. Discover the impact!

March 19, 2025 14:51 IST

Zydus Lifesciences share price today, March 13

16% cut in Zydus Lifesciences target: 4 big worries for Nuvama are…

Nuvama cuts Zydus Lifesciences target by 16%, citing weak synergy with Amplitude acquisition. Read more about the financial outlook now!

March 13, 2025 09:53 IST

Zydus Lifesciences: Can It Successfully Move Up the Value Chain? . (Image Source: Reuters)

Zydus Lifesciences – Will it succeed in aggressively moving up the value chain?

Zydus Lifesciences is working to advance its position in the global pharmaceutical sector by increasing its focus on medical technology.…

March 13, 2025 06:04 IST

We plan to focus on high precision MedTech products to cater to global demand: Zydus Lifesciences MD

Amplitude Surgical has experienced significant growth over the last four years, driven by new product development, international growth, investments in…

March 11, 2025 15:47 IST

Zydus acquire majority stake of 86 percent in Amplitude Surgical to strengthen its MedTech portfolio

Zydus acquires majority stake of 86 percent in Amplitude Surgical to strengthen its MedTech portfolio

Medical Technology includes medical devices and related scientific infrastructure that directly contribute to the development of these products and solutions.

March 11, 2025 14:12 IST

Jefferies bets big on these 3 pharma stocks- Find out why

Jefferies backs Lupin, Zydus, and Biocon amid shifting US pharma market shares. Discover why these stocks are set to shine.

March 4, 2025 14:31 IST

Zydus to develop the world’s first combination vaccine to offer protection against shigellosis and typhoid

Typhoid is already a disease of concern globally and various endemic countries already have TCV as part of their national…

March 4, 2025 13:26 IST

Related News

Govt extended ITR AY 2025-26 deadline, but only 4.56 crore returns filed so far

China exits Pakistan’s $60 billion CPEC flagship project; Islamabad turns to ADB for funding

China exits Pakistan’s $60 billion economic corridor project; Islamabad turns to ADB for funding

New Zealand visa application, visa police certificates, visa Regional Passport Office, Indian Ministry of External Affairs, Immigration New Zealand

New Zealand issues new rules for Indian national visa applicants

Motilal Oswal stock picks, M&M share price, HDFC Life stock

Motilal Oswal’s top 3 ‘Buy’ picks after GST rate cut with upto 17% upside potential

Canada, French-speaking foreigners, Express Entry draw results, released, announced, French language proficiency, permanent residency

Canada invites French speakers to apply for permanent residence

Trump’s tariff pivot: Signs order to exempt over 45 import categories-See what’s covered

World News13 min ago

President Trump has signed an executive order granting tariff exemptions to trading partners for industrial exports like nickel and gold, as well as pharmaceutical compounds and chemicals. The move is in line with Trump’s aim to decrease U.S. trade deficits and gain concessions from partners. The exemptions, effective Monday, cover items that cannot be produced in the U.S.

View all shorts